Comparison between Midfield Industries IPO and Parabolic Drugs IPO.
Midfield Industries IPO is a Mainboard Bookbuilding IPO proposed to list at BSE while Parabolic Drugs IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Midfield Industries IPO is up to ₹59.85 Cr whereas the issue size of the Parabolic Drugs IPO is up to ₹200.00 Cr. The final issue price of Midfield Industries IPO is ₹133.00 per share and of Parabolic Drugs IPO is ₹75.00 per share.
| Midfield Industries IPO | Parabolic Drugs IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹126.00 per share | ₹75.00 per share |
| Issue Price (Upper) | ₹133.00 per share | ₹85.00 per share |
| Issue Price (Final) | ₹133.00 per share | ₹75.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 50 shares | 80 shares |
| Fresh Issue Size | 45,00,001 shares | 2,46,40,965 shares |
| Fresh Issue Size (Amount) | up to ₹59.85 Cr | up to ₹184.81 Cr |
| OFS Issue Size | 0 shares | 20,25,702 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹15.19 Cr |
| Issue Size Total | 45,00,001 shares | 2,66,66,667 shares |
| Issue Size Total (Amount) | up to ₹59.85 Cr | up to ₹200.00 Cr |
Midfield Industries IPO opens on Jul 19, 2010, while Parabolic Drugs IPO opens on Jun 14, 2010. The closing date of Midfield Industries IPO and Parabolic Drugs IPO is Jul 21, 2010, and Jun 17, 2010, respectively.
| Midfield Industries IPO | Parabolic Drugs IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jul 19, 2010 | Jun 14, 2010 |
| Issue Close | Jul 21, 2010 | Jun 17, 2010 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Aug 04, 2010 | Jul 01, 2010 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Midfield Industries IPO P/E ratio is , as compared to Parabolic Drugs IPO P/E ratio of .
| Midfield Industries IPO | Parabolic Drugs IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 79.76 | 63.21 | ||||
| Promoter Shareholding (Post-Issue) | 51.77 | 38.04 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹170.52 Cr. | ₹464.19 Cr. | ||||
| ROE | ||||||
| ROCE | 6.21 | |||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 24.16 | 19.96 |
In the Midfield Industries IPO Retail Individual Investors (RII) are offered 15,75,000 shares while in Parabolic Drugs IPO retail investors are offered 15,75,000 shares. Qualified Institutional Buyers (QIB) are offered 22,50,000 shares in Midfield Industries IPO and 1,30,83,333 shares in Parabolic Drugs IPO.
| Midfield Industries IPO | Parabolic Drugs IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 22,50,000 shares | 1,30,83,333 shares |
| NII | 6,75,000 shares | 39,25,000 shares |
| RII | 15,75,000 shares | 91,58,334 shares |
| Employee | 5,00,000 shares | |
| Others | ||
| Total | 45,00,000 shares | 2,66,66,667 shares |
Midfield Industries IPO subscribed 12.92x in total, whereas Parabolic Drugs IPO subscribed 1.04x.
| Midfield Industries IPO | Parabolic Drugs IPO | |
|---|---|---|
| QIB (times) | 1.86x | 1.48x |
| NII (times) | 48.41x | 1.20x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 13.51x | 0.40x |
| Employee (times) | 0.11x | |
| Other (times) | ||
| Total (times) | 12.92x | 1.04x |
